DC-SIGN/CD209 Antikörper (Extracellular Domain)
Kurzübersicht für DC-SIGN/CD209 Antikörper (Extracellular Domain) (ABIN1733537)
Target
Alle DC-SIGN/CD209 (CD209) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 277-293, Extracellular Domain
-
Spezifität
- Reacts with the extracellular domain of human DC-SIGN (ED).
-
Aufreinigung
- Purified
-
Immunogen
- Peptide corresponding to aa 277-293 of human DC-SIGN.
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
Working dilution: Optimal dilutions should be determined by the end user.
The following are guidelines only:
WB1 - 2 μg/mL
Positive control: Human placenta tissue lysate -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Buffer
- PBS, pH 7.4
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Dilute in PBS or medium which is identical to that used in the assay system.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store in aliquots at -20°C. Antibodies are guaranteed for 6 months from date of receipt.
-
Haltbarkeit
- 6 months
-
-
- DC-SIGN/CD209 (CD209) (CD209)
-
Andere Bezeichnung
- DC-SIGN
-
Hintergrund
-
DC-SIGN is a dendritic cell receptor that can capture and transport HIV from mucosal areas to remote lymph nodes where HIV is then transferred to CD4+ T lymphocytes. Multiple strains of HIV-1, HIV-2, and SIV bind to dendritic cells via DC-SIGN. DC-SIGN is expressed in mucosal tissues, placenta, small intestine, and rectum.
CD209 antigen C-type lectin domain family 4 member L Dendritic cell-specific ICAM-3-grabbing non-integrin 1, DC-SIGN, DC-SIGN1 CD209 Gene name: CD209, CLEC4L -
Gen-ID
- 30835
-
UniProt
- Q9NNX6
Target
-